NCT06328413

Brief Summary

The aim of this study is to compare leukocyte and platelet-rich fibrin (L-PRF) and photobiomodulation (PBM) applications, which have been repeatedly reported to be superior to control groups, in terms of pain, soft tissue and bone healing in tooth extraction sockets.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2021

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

March 11, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 25, 2024

Completed
Last Updated

March 25, 2024

Status Verified

March 1, 2024

Enrollment Period

1.2 years

First QC Date

March 11, 2024

Last Update Submit

March 21, 2024

Conditions

Keywords

photobiomodulationL-PRFpainbone healingsoft tissue healingthird molar

Outcome Measures

Primary Outcomes (1)

  • Newly formed bone (Healing at extraction sockets)

    Newly formed bone assessed on Panoramic x-ray with Image J programme

    Bone healing at the end of 1st and 3rd months after third molar extractions

Secondary Outcomes (2)

  • Soft tissue healing

    End of 1st, 2nd week and 1st month after tooth extraction

  • Probing depth

    End of 1st, 2nd week and 1st month after tooth extraction

Other Outcomes (1)

  • Postoperative pain

    Postoperative 2nd, 4th and 7th days

Study Arms (2)

Photobiomodulation group

EXPERIMENTAL

Photobiomodulation application at different extra and intraoral points for 60 seconds with a wavelength of 940 nm in repeated sessions after the extraction of third molar

Device: photobiomodulation

Leukocyte and platelet-rich fibrin group

ACTIVE COMPARATOR

Leukocyte and platelet rich fibrin ( blood product centrifuged for 12 minutes at 2700rpm) application after third molar extraction, single session.

Other: Leukocyte and Platelet Rich Fibrin

Interventions

Photobiomodulation application at different extraoral and intraoral points for 60 seconds with a wavelength of 940 nm in repeated sessions after the extraction of third molar

Photobiomodulation group

Leukocyte and platelet rich fibrin ( blood product centrifuged for 12 minutes at 2700rpm) application after third molar extraction, single session.

Leukocyte and platelet-rich fibrin group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) Class-I healthy volunteers
  • Between 18 and 40 years of age who had wisdom teeth (Pell and Gregory Class II, Position B) with bone retention in bilateral symmetrical position with an indication for extraction, and had second molars in the mouth,
  • Not use steroids or anti-inflammatory drugs in the last 3 months.

You may not qualify if:

  • Patients with pericoronitis,
  • Smoking habits
  • Active periodontal disease
  • Pregnancy,
  • Breastfeeding
  • Unable to give personal consent, and those with missing physical examination and follow-up records were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akdeniz University

Antalya, Merkez, 07058, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Interventions

Low-Level Light TherapyLeukocyte Count

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapyBlood Cell CountCell CountCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHematologic TestsInvestigative TechniquesCell Physiological PhenomenaBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Cennet N Eroglu, DDS,PhD

    Akdeniz University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Since the groups were formed on the same individual, only which side would be the PBM and which side would be the L-PRF group was determined by coin-flip method (simple randomization).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc Prof Dr

Study Record Dates

First Submitted

March 11, 2024

First Posted

March 25, 2024

Study Start

April 20, 2020

Primary Completion

June 21, 2021

Study Completion

September 21, 2021

Last Updated

March 25, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations